An interview with ‘The Hemingway’ directors Evan Mathis and Patrick Sean O’Brien on how they captured the truth and the humor ...

On a video call in early September, Sarah Tabrizi first saw the data that she and other researchers studying Huntington’s ...

Last year, one of our group mentioned that he was thankful to be an American. This year, we have a six-part documentary on PBS by Ken Burns explaining to us what that means. “The American Revolution” ...

Researchers have found a new treatment for Huntington's disease, an inherited genetic brain disease that affects over 41,000 Americans, in breakthrough clinical trial that involved at least one ...

Selena Quintanilla is being celebrated in the new Netflix documentary Selena y Los Dinos: A Family’s Legacy, which features archival footage and interviews with her loved ones. From her early ...

Kevin Lynch is a London-born, Dublin-based writer and journalist. The author of Steve Jobs: A Biographic Portrait, Kevin is a regular feature writer for a number of tech sites and the former ...

Hitler’s DNA: Blueprint of a Dictator premieres on Channel 4 in the UK on November 15 and will claim that its analysis of the dictator’s DNA “reveals he suffered from a form of Kallmann Syndrome, ...

A new documentary about Tejano legend Selena Quintanilla will debut on Nov. 17 on Netflix. Directed by Isabel Castro, "Selena y Los Dinos: A Family's Legacy" follows the life and impact of Selena and ...

SEATTLE — After its world premiere at the 2025 Tribeca Festival. The film, "Matter of Time," had its opening night here in West Seattle. The film is a powerful documentary that blends music, science ...

Despite the best efforts of modern medicine, Huntington’s disease is a condition that still comes with a tragic prognosis. Primarily an inherited disease, its main symptoms concern degeneration of the ...

In 2025, nonprofits, charities and service organizations are navigating an economy in crisis and political machinations that often put their budgets and, sometimes, their very existence in peril. And ...

UniQure stock is rated a Buy with a $66 price target, offering upside after recent FDA pushback on AMT-130 Huntington's therapy trial design. AMT-130 is the first disease-modifying therapy for ...